Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation

Authors: Chunlin Shao, Melvyn Folkard, Kathryn D Held, Kevin M Prise

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

Radiation-induced bystander responses, where cells respond to their neighbours being irradiated are being extensively studied. Although evidence shows that bystander responses can be induced in many types of cells, it is not known whether there is a radiation-induced bystander effect in breast cancer cells, where the radiosensitivity may be dependent on the role of the cellular estrogen receptor (ER). This study investigated radiation-induced bystander responses in estrogen receptor-positive MCF-7 and estrogen receptor-negative MDA-MB-231 breast cancer cells.

Methods

The influence of estrogen and anti-estrogen treatments on the bystander response was determined by individually irradiating a fraction of cells within the population with a precise number of helium-3 using a charged particle microbeam. Damage was scored as chromosomal damage measured as micronucleus formation.

Results

A bystander response measured as increased yield of micronucleated cells was triggered in both MCF-7 and MDA-MB-231 cells. The contribution of the bystander response to total cell damage in MCF-7 cells was higher than that in MDA-MB-231 cells although the radiosensitivity of MDA-MB-231 was higher than MCF-7. Treatment of cells with 17β-estradiol (E2) increased the radiosensitivity and the bystander response in MCF-7 cells, and the effect was diminished by anti-estrogen tamoxifen (TAM). E2 also increased the level of intracellular reactive oxygen species (ROS) in MCF-7 cells in the absence of radiation. In contrast, E2 and TAM had no influence on the bystander response and ROS levels in MDA-MB-231 cells. Moreover, the treatment of MCF-7 cells with antioxidants eliminated both the E2-induced ROS increase and E2-enhanced bystander response triggered by the microbeam irradiation, which indicates that ROS are involved in the E2-enhanced bystander micronuclei formation after microbeam irradiation.

Conclusion

The observation of bystander responses in breast tumour cells may offer new potential targets for radiation-based therapies in the treatment of breast cancer.
Appendix
Available only for authorised users
Literature
1.
Prise KM, Schettino G, Folkard M, Held KD: New insights on cell death from radiation exposure. The lancet oncology. 2005, 6 (7): 520-528. 10.1016/S1470-2045(05)70246-1.CrossRefPubMed
2.
Nagasawa H, Little JB: induction of sister chromatid exchanges by extremely low doses of a-particles. Cancer Research. 1992, 52: 6394-6396.PubMed
3.
Azzam EI, de Toledo SM, Little JB: Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proceedings of the National Academy of Sciences of the United States of America. 2001, 98 (2): 473-478. 10.1073/pnas.011417098.PubMedPubMedCentral
4.
Lyng FM, Seymour CB, Mothersill C: Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis. British Journal of Cancer. 2000, 83 (9): 1223-1230. 10.1054/bjoc.2000.1433.CrossRefPubMedPubMedCentral
5.
Mothersill C, Seymour C: Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of irradiated cells. International Journal of Radiation Biology. 1997, 71: 421-427. 10.1080/095530097144030.CrossRefPubMed
6.
Shao C, Furusawa Y, Aoki M, Matsumoto H, Ando K: Nitric oxide-mediated bystander effect induced by heavy-ions in human salivary gland tumour cells. International Journal of Radiation Biology. 2002, 78 (9): 837-844. 10.1080/09553000210149786.CrossRefPubMed
7.
Shao C, Furusawa Y, Kobayashi Y, Funayama T, Wada S: Bystander effect induced by counted high-LET particles in confluent human fibroblasts: a mechanistic study. FASEB Journal. 2003, 17 (11): 1422-1427. 10.1096/fj.02-1115com.CrossRefPubMed
8.
Zhou H, Randers-Pehrson G, Waldren CA, Vannais D, Hall EJ, Hei TK: Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 2000, 97 (5): 2099-2104. 10.1073/pnas.030420797.CrossRefPubMedPubMedCentral
9.
Prise KM, Belyakov OV, Folkard M, Michael BD: Studies of bystander effects in human fibroblasts using a charged particle microbeam. International Journal of Radiation Biology. 1998, 74: 793-798. 10.1080/095530098141087.CrossRefPubMed
10.
Shao C, Folkard M, Michael BD, Prise KM: Targeted cytoplasmic irradiation induces bystander responses. Proceedings of the National Academy of Sciences of the United States of America. 2004, 101 (37): 13495-13500. 10.1073/pnas.0404930101.CrossRefPubMedPubMedCentral
11.
Yang H, Asaad N, Held KD: Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts. Oncogene. 2005, 24: 2096-103. 10.1038/sj.onc.1208439.CrossRefPubMed
12.
Burdak-Rothkamm S, Short SC, Folkard M, Rothkamm K, Prise KM: ATR-dependent radiation-induced gammaH2AX foci in bystander primary human astrocytes and glioma cells. Oncogene. 2007, 26 (7): 993-1002. 10.1038/sj.onc.1209863.CrossRefPubMed
13.
Mothersill C, Stamato TD, Perez ML, Cummins R, Mooney R, Seymour CB: Involvement of energy metabolism in the production of 'bystander effects' by radiation. Br J Cancer. 2000, 82 (10): 1740-1746. 10.1054/bjoc.2000.1109.CrossRefPubMedPubMedCentral
14.
Nagasawa H, Cremesti A, Kolesnick R, Fuks Z, Little JB: Involvement of membrane signaling in the bystander effect in irradiated cells. Cancer Research. 2002, 62 (9): 2531-2534.PubMed
15.
Deshpande A, Goodwin EH, Bailey SM, Marrone BL, Lehnert BE: Alpha-particle-induced sister chromatid exchange in normal human lung fibroblasts: Evidence for an extranuclear target. Radiation Research. 1996, 145: 260-267. 10.2307/3578980.CrossRefPubMed
16.
Ponnaiya B, Jenkins-Baker G, Brenner DJ, Hall EJ, Randers-Pehrson G, Geard CR: Biological responses in known bystander cells relative to known microbeam-irradiated cells. Radiation Research. 2004, 162 (4): 426-432. 10.1667/RR3236.CrossRefPubMed
17.
Shao C, Folkard M, Michael BD, Prise KM: Bystander signaling between glioma cells and fibroblasts targeted with counted particles. Int J Cancer. 2005, 116 (1): 45-51. 10.1002/ijc.21003.CrossRefPubMed
18.
Little JB: Radiation carcinogenesis. Carcinogenesis. 2000, 21 (3): 397-404. 10.1093/carcin/21.3.397.CrossRefPubMed
19.
Zhou H, Suzuki M, Randers-Pehrson G, Vannais D, Chen G, Trosko JE, Waldren CA, Hei TK: Radiation risk to low fluences of alpha particles may be greater than we thought. Proceedings of the National Academy of Sciences of the United States of America. 2001, 98 (25): 14410-14415. 10.1073/pnas.251524798.CrossRefPubMedPubMedCentral
20.
Lorimore SA, Coates PJ, Wright EG: Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene. 2003, 22 (45): 7058-7069. 10.1038/sj.onc.1207044.CrossRefPubMed
21.
Hall EJ, Hei TK: Genomic instability and bystander effects induced by high-LET radiation. Oncogene. 2003, 22 (45): 7034-7042. 10.1038/sj.onc.1206900.CrossRefPubMed
22.
Lewis DA, Mayhugh BM, Qin Y, Trott K, Mendonca MS: Production of delayed death and neoplastic transformation in CGL1 cells by radiation-induced bystander effects. Radiation Research. 2001, 156 (3): 251-258. 10.1667/0033-7587(2001)156[0251:PODDAN]2.0.CO;2.CrossRefPubMed
23.
Sawant SG, Randers-Pehrson G, Geard CR, Brenner DJ, Hall EJ: The bystander effect in radiation oncogenesis: I. Transformation in C3H 10T1/2 cells in vitro can be initiated in the unirradiated neighbors of irradiated cells. Radiation Research. 2001, 155 (3): 397-401. 10.1667/0033-7587(2001)155[0397:TBEIRO]2.0.CO;2.CrossRefPubMed
24.
Azzam EI, de Toledo SM, Gooding T, Little JB: Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat Res. 1998, 150 (5): 497-504. 10.2307/3579865.CrossRefPubMed
25.
Tartier L, Gilchrist S, Burdak-Rothkamm S, Folkard M, Prise KM: Cytoplasmic irradiation induces mitochondrial-dependent 53BP1 protein relocalization in irradiated and bystander cells. Cancer Research. 2007, 67 (12): 5872-5879. 10.1158/0008-5472.CAN-07-0188.CrossRefPubMedPubMedCentral
26.
Shao C, Furusawa Y, Aoki M, Ando K: Role of gap junctional intercellular communication in radiation-induced bystander effects in human fibroblasts. Radiation Research. 2003, 160 (3): 318-323. 10.1667/RR3044.CrossRefPubMed
27.
Azzam EI, de Toledo SM, Little JB: Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect. Oncogene. 2003, 22 (45): 7050-7057. 10.1038/sj.onc.1206961.CrossRefPubMed
28.
Mitchell SA, Randers-Pehrson G, Brenner DJ, Hall EJ: The bystander response in C3H 10T1/2 cells: the influence of cell-to-cell contact. Radiation Research. 2004, 161 (4): 397-401. 10.1667/RR3137.CrossRefPubMed
29.
Iyer R, Lehnert BE: Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Research. 2000, 60 (5): 1290-1298.PubMed
30.
Lehnert BE, Goodwin EH: Extracellular factor(s) following exposure to a-particles can cause sister chromatid exchanges in normal human cells. Cancer Research. 1997, 57: 2164-2171.PubMed
31.
Narayanan PK, Goodwin EH, Lehnert BE: a-particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Research. 1997, 57: 3963-3971.PubMed
32.
Shao C, Stewart V, Folkard M, Michael BD, Prise KM: Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells. Cancer Research. 2003, 63 (23): 8437-8442.PubMed
33.
Matsumoto H, Hayashi S, Hatashita M, Ohnishi K, Shioura H, Ohtsubo T, Kitai R, Ohnishi T, Kano E: Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiation Research. 2001, 155 (3): 387-396. 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2.CrossRefPubMed
34.
Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB, Zaider M: Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proceedings of the National Academy of Sciences of the United States of America. 2003, 100 (24): 13761-13766. 10.1073/pnas.2235592100.CrossRefPubMedPubMedCentral
35.
Schmidberger H, Hermann RM, Hess CF, Emons G: Interactions between radiation and endocrine therapy in breast cancer. Endocrine-related cancer. 2003, 10 (3): 375-388. 10.1677/erc.0.0100375.CrossRefPubMed
36.
Razandi M, Pedram A, Levin ER: Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Molecular endocrinology (Baltimore, Md. 2000, 14 (9): 1434-1447. 10.1210/me.14.9.1434.CrossRef
37.
Wazer DE, Tercilla OF, Lin PS, Schmidt-Ullrich R: Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen. The British journal of radiology. 1989, 62 (744): 1079-1083.CrossRefPubMed
38.
Villalobos M, Becerra D, Nunez MI, Valenzuela MT, Siles E, Olea N, Pedraza V, Ruiz de Almodovar JM: Radiosensitivity of human breast cancer cell lines of different hormonal responsiveness. Modulatory effects of oestradiol. International Journal of Radiation Biology. 1996, 70 (2): 161-169. 10.1080/095530096145157.CrossRefPubMed
39.
Amorino GP, Freeman ML, Choy H: Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol. Radiat Res. 2000, 153 (4): 384-391. 10.1667/0033-7587(2000)153[0384:EOREIV]2.0.CO;2.CrossRefPubMed
40.
Sarkaria JN, Miller EM, Parker CJ, Jordan VC, Mulcahy RT: 4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro. Breast cancer research and treatment. 1994, 30 (2): 159-165. 10.1007/BF00666060.CrossRefPubMed
41.
Paulsen GH, Strickert T, Marthinsen AB, Lundgren S: Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta oncologica (Stockholm, Sweden). 1996, 35 (8): 1011-1019. 10.3109/02841869609100720.CrossRef
42.
Folkard M, Vojnovic B, Prise KM, Bowey AG, Locke RJ, Schettino G, Michael BD: A charged-particle microbeam I. Development of an experimental system for targeting cells individually with counted particles. Int J Radiat Biol. 1997, 72: 375-385. 10.1080/095530097143158.CrossRefPubMed
43.
Mobley JA, Brueggemeier RW: Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis. 2004, 25 (1): 3-9. 10.1093/carcin/bgg175.CrossRefPubMed
44.
Folkard M, Vojnovic B, Hollis KJ, Bowey AG, Watts SJ, Schettino G, Prise KM, Michael BD: A charged particle microbeam: II A single-particle micro-collimation and detection system. International Journal of Radiation Biology. 1997, 72: 387-395. 10.1080/095530097143167.CrossRefPubMed
45.
Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DE, Tice R, Waters MD, Aitio A: IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutation research. 2000, 463 (2): 111-172. 10.1016/S1383-5742(00)00049-1.CrossRefPubMed
46.
Arnold SF, Tims E, Bluman EM, McGrath BE: Regulation of transforming growth factor beta1 by radiation in cells of two human breast cancer cell lines. Radiat Res. 1999, 152 (5): 487-492. 10.2307/3580144.CrossRefPubMed
47.
Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S, Dent P: Radiation-induced cell signaling: inside-out and outside-in. Molecular cancer therapeutics. 2007, 6 (3): 789-801. 10.1158/1535-7163.MCT-06-0596.CrossRefPubMed
48.
Shao C, Folkard M, Prise KM: Role of TGF-beta1 and nitric oxide in the bystander response of irradiated glioma cells. Oncogene. 2008, 27 (4): 434-440. 10.1038/sj.onc.1210653.CrossRefPubMed
49.
Shao C, Prise KM, Folkard M: Signaling factors for irradiated glioma cells induced bystander responses in fibroblasts. Mutat Res. 2008, 638 (1-2): 139-145.CrossRefPubMed
50.
Liehr JG: Is estradiol a genotoxic mutagenic carcinogen?. Endocrine reviews. 2000, 21 (1): 40-54. 10.1210/er.21.1.40.PubMed
51.
Fischer WH, Keiwan A, Schmitt E, Stopper H: Increased formation of micronuclei after hormonal stimulation of cell proliferation in human breast cancer cells. Mutagenesis. 2001, 16 (3): 209-212. 10.1093/mutage/16.3.209.CrossRefPubMed
52.
Stopper H, Schmitt E, Gregor C, Mueller SO, Fischer WH: Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells. Mutagenesis. 2003, 18 (3): 243-247. 10.1093/mutage/18.3.243.CrossRefPubMed
53.
Han X, Liehr JG: 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 1994, 54 (21): 5515-5517.PubMed
54.
Hurh YJ, Chen ZH, Na HK, Han SY, Surh YJ: 2-Hydroxyestradiol induces oxidative DNA damage and apoptosis in human mammary epithelial cells. J Toxicol Environ Health A. 2004, 67 (23-24): 1939-1953. 10.1080/15287390490514598.CrossRefPubMed
55.
Chhipa RR, Bhat MK: Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas. Journal of cellular biochemistry. 2007, 101 (1): 68-79. 10.1002/jcb.21153.CrossRefPubMed
56.
Alexandre J, Hu Y, Lu W, Pelicano H, Huang P: Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Research. 2007, 67 (8): 3512-3517. 10.1158/0008-5472.CAN-06-3914.CrossRefPubMed
Metadata
Title
Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation
Authors
Chunlin Shao
Melvyn Folkard
Kathryn D Held
Kevin M Prise
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-184

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue

Research article

Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis

Research article

Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

Research article

The development and deployment of Common Data Elements for tissue banks for translational research in cancer – An emerging standard based approach for the Mesothelioma Virtual Tissue Bank

Research article

Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma

Research article

Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England

Research article

The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits